Patents by Inventor Jan-Michael Peters

Jan-Michael Peters has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7410774
    Abstract: Method for identifying compounds that interfere with or modulate sister chromatid separation in animal or plant cells by modulating a protease with separin-like cysteine endopeptidase activity. Inhibitors of separin activity are useful in cancer therapy, to prevent birth defects and to increase ploidy in plants.
    Type: Grant
    Filed: February 15, 2000
    Date of Patent: August 12, 2008
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Frank Uhlmann, Kim Nasmyth, Jan-Michael Peters, Irene Waizenegger, Sara Buonomo, Rosemary Clyne
  • Publication number: 20050014206
    Abstract: A screening method for identifying specific APC inhibitors comprises a primary screen in which a compound is tested for its ability to interfere with binding of CDH1 or CDC20 to the APC and a secondary screen, in which the compound is tested for its ability to interfere with the activation of the APC by CDH1 or CDC20.
    Type: Application
    Filed: April 16, 2004
    Publication date: January 20, 2005
    Inventors: Hartmut Vodermaier, Christian Gieffers, Sebastian Maurer-Stroh, Frank Eisenhaber, Jan-Michael Peters, Michael Gmachl
  • Publication number: 20020164620
    Abstract: Screening methods for identifying separase inhibitors based on active forms of separase and compounds identified in such methods.
    Type: Application
    Filed: January 22, 2002
    Publication date: November 7, 2002
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Jan-Michael Peters, Irene Waizenegger, Wolfgang Sommergruber
  • Publication number: 20020028472
    Abstract: Screening methods for identifying compounds that inhibit the ubiquitination reaction mediated by the APC are based on the ability of the APC subunit APC11 to form multiubiquitin chains. A compound's ability to interfere with self-ubiquitination of APC11, with the formation of multiubiquitin chains independent of their attachment to APC11 or with ubiquitination of an APC substrate can be measured.
    Type: Application
    Filed: June 29, 2001
    Publication date: March 7, 2002
    Inventors: Michael Gmachl, Jan-Michael Peters, Christian Gieffers
  • Patent number: 5726025
    Abstract: The present invention provides a systematic and practical approach for the identification of candidate agents able to inhibit ubiquitin-mediated degradation of a cell-cycle regulatory protein, such as cyclins. One aspect of the present invention relates to a method for identifying an inhibitor of ubiquitin-mediated proteolysis of a cell-cycle regulatory protein by (i) providing a ubiquitin-conjugating system that includes the regulatory protein and ubiquitin under conditions which promote the ubiquitination of the target protein, and (ii) measuring the level of ubiquitination of the subject protein brought about by the system in the presence and absence of a candidate agent. A decrease in the level of ubiquitin conjugation is indicative of an inhibitory activity for the candidate agent.
    Type: Grant
    Filed: April 20, 1995
    Date of Patent: March 10, 1998
    Assignee: President and Fellows of Harvard College
    Inventors: Marc W. Kirschner, Randall W. King, Jan-Michael Peters